FBInvestor
Stocks / Ascendis Pharma A/S
Institutional Ownership

Ascendis Pharma A/S

CUSIP 04351P101SPONSORED ADRASNDQ1 2026

13D / 13G Filings
68
Schedule 13D/13G on record
Beneficial Filers
15
Distinct reporting persons
Largest Stake
21.2%
Max % of class reported
Institutional Holders
264
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

68 filings · latest Feb 11, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 11, 2026Westfield Capital Management Company, L.P.13G/A8.5%5.19MSEC
2Feb 3, 2026Artisan Partners Asset Management Inc.13G/A5.3%3.23MSEC
3Nov 14, 2025T. Rowe Price Investment Management, Inc.13G/A4.8%2.67MSEC
4Nov 14, 2025Janus Henderson Group PLC13G/A7.8%4.32MSEC
5Aug 14, 2025T. Rowe Price Investment Management, Inc.13G/A6.4%3.58MSEC
6Aug 14, 2025Janus Henderson Group PLC13G/A8.0%4.43MSEC
7Aug 13, 2025Capital International Investors13G5.6%3.11MSEC
8May 14, 2025T. Rowe Price Investment Management, Inc.13G5.0%3.05MSEC
9May 14, 2025Janus Henderson Group PLC13G/A7.4%4.50MSEC
10May 12, 2025Fmr LLC13G/A8.0%4.65MSEC

58 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Ascendis Pharma A/S.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →
#FundSharesValue
1Ra Capital Management, L.P.10.28M$2.35B
2Avoro Capital Advisors LLC5.06M$1.16B
3Westfield Capital Management Co LP4.81M$1.10B
4Fmr LLC3.88M$886.69M
5Artisan Partners Limited Partnership3.23M$738.84M
6Franklin Resources Inc2.05M$469.34M
7Capital International Investors1.96M$448.05M
8Massachusetts Financial Services Co /Ma/1.86M$425.57M
9Wellington Management Group LLP1.76M$402.02M
10Perceptive Advisors LLC1.53M$350.28M